It appears it is not only bloggers that are feeling the heat from the government in regards to their relationships with the brands they write about, but cosmetic dermatologists as well. Recently the FDA made an example of Dr. Leslie Baumann by sending her a warning when she was sourced for several beauty magazine articles regarding her positive praise of Dysport, the newly approved Botox competitor created by Medicis prior to such approval. The warning appears to have more to do with disclosure than anything else, which, mark my words, will be the buzzword of 2010 due in part to both the FTC and FDA.
It is a publicist's job to land their client in A+ publications and in this fierce competitive world of Beauty PR, everyone wants to be first to be sourced for being in the know about the latest and greatest beauty treatment. However, Dr. Baumann's publicists should've been more careful considering her relationship with Medicis as an "investigator" for Dysport. In all of the articles she was quoted in, not once did she disclose this relationship, but merely indicated her praise that the neurotoxin was more effective than Botox.
Dr. Baumann was given 10 days to "clean up her act;" I wonder how her publicists will handle that.
Posted by Shannon Nelson on January 25, 2010 5:28 PM
| Permalink
Comments (1)
I am glad this warning was sent. Too many magazines and physicians a like are promoting misleading information based on how much they are paid by that product promoter. They promote based on relationships and emotions rather than scientific and proven facts. The bottom line is that DYSPORT does not last longer than BOTOX. In fact all clinical data suggests otherwise. There is also not one single published study that suggests DYSPORT or BOTOX have a quicker onset. This was clearly an effort to create buzz rather than give pertinent information.
Posted by![]()
Beauty Girl |
February 1, 2010 12:43 PM
Posted on February 1, 2010 12:43